Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.
Chandrakasan S, Allen CE, Bhatla D, Carter J, Chien M, Cooper R, Draper L, Eckstein OS, Hanna R, Hays JA, Hermiston ML, Hinson AP, Hobday PM, Isakoff MS, Jordan MB, Leiding JW, Modica R, Nakano TA, Oladapo A, Patel SA, Pednekar P, Riskalla M, Sarangi SN, Satwani P, Tandra A, Walkovich KJ, Yee JD, Zoref-Lorenz A, Behrens EM; REAL-HLH Investigators.
Chandrakasan S, et al. Among authors: cooper r.
Immunotherapy. 2025 May;17(7):461-478. doi: 10.1080/1750743X.2025.2509478. Epub 2025 Jun 17.
Immunotherapy. 2025.
PMID: 40528399
Free article.